Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
10/2006
10/10/2006US7119206 drugs such as 12-[4-(2-Piperidin-1-yl-ethoxy)-phenyl]-7,12-dihydro-benzo[a]anthracene-3,9-diol, used for prevention of bone and cardiovascular disorders, as hypotensive, thrombolytic and anticholesterol agents
10/10/2006US7119198 beta-aryl-alpha-oxysubstituted alkylcarboxylic acids, usch as Ethyl (E/Z)-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropenoate, used as antilipemic or hypoglycemic agents
10/10/2006US7118899 Introducing a reagent comprising a hydrophobic fluorescent ion; measuring energy transfer
10/10/2006CA2268799C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
10/05/2006WO2006105127A2 Hydroxysteroid dehydrogenase inhibitors
10/05/2006US20060223995 Superhigh purity ionic liquid
10/05/2006US20060223836 New phenylalanine derivatives
10/05/2006US20060223726 Photo-labile pro-fragrance conjugates
10/05/2006CA2603122A1 Phenyl and pyridyl lta4h modulators
10/04/2006EP1706371A1 Aryl aniline derivatives as beta2 adrenergic receptor agonists
10/04/2006EP1451194B1 Preparation of levofloxacin hemihydrate
10/03/2006US7115780 For therapy of ulcers, pancreatitis, obesity, urinary incontinence and pollakiuria
10/03/2006US7115750 Melanin concentrating hormone antagonist
10/03/2006US7115646 Cyclic diamines and derivatives as factor Xa inhibitors
09/2006
09/28/2006WO2006101009A1 Nile red-based red luminescent compound, and luminescent element using the same
09/28/2006WO2006047503A3 Inhibitors of c-fms kinase
09/28/2006WO2005064008A9 Method and compositions for identifying anti-hiv therapeutic compounds
09/28/2006WO2004070352A3 Methods, mixtures, kits and compositions pertaining to analyte determination
09/28/2006US20060217550 One pot process; cyclization; 4-(4-nitrophenyl)-3-oxomorpholine; Factor Xa inhibitors; , myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty and claudicatio intermittens
09/27/2006EP1286967B1 Cyclohexane derivatives and their use as therapeutic agents
09/26/2006US7112586 Substituted diamine derivatives useful as motilin antagonists
09/26/2006US7112584 Antiinflammatory agents; antiarthritic agents; antiallergens; antiinflammatory agents
09/21/2006WO2006067587A3 Nonnucleoside inhibitors of hiv-1 reverse transcriptase
09/21/2006US20060211860 Compounds for the treatment of Alzheimer's disease
09/21/2006US20060211675 Preventives/remedies for urinary disturbance
09/21/2006US20060211657 Prodrugs of 2,4-pyrimidinediamine compounds and their uses
09/21/2006US20060211097 Process for producing enantiopure beta-amino acid derivatives, and enantiopure beta-amino acid derivatives
09/21/2006CA2600468A1 Stabilized compositions of volatile alkylating agents and methods of using thereof
09/20/2006EP1701724A2 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
09/20/2006EP0889889B1 Piperazine and piperidine compounds
09/20/2006CN1835911A Novel method for synthesizing esters of N-[(S)-1-carboxybutyl]-(S)-alanine and use thereof for synthesizing perindopril
09/19/2006US7109153 Photo-labile pro-fragrance conjugates
09/14/2006WO2006094994A1 Use of 4-aminopyrimidines for the prevention of fungal pests novel 4-aminopyrimidines method for production thereof and agents comprising the same
09/14/2006WO2004073634A3 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
09/14/2006US20060205772 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type I
09/14/2006US20060205719 Novel compounds having an antibacterial activity
09/14/2006DE102006006251A1 Cyclische Mannich-Produkte Cyclic Mannich products
09/13/2006CN1832933A Method for production of n-aryl morpholinones
09/13/2006CN1832912A Clear photopolymerizable systems for the preparation of high thickness coatings
09/13/2006CN1832761A Thiotungstate analogues and uses thereof
09/13/2006CN1830941A Compound having hydroxycarbonyl-halogenoalkyl side chain
09/12/2006US7105701 Multibinding compounds for agonists for phenolic derivatives for adrenergic receptors with carriers
09/12/2006US7105683 Process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts of ranelic acid and their hydrates
09/12/2006US7105662 Method of producing N-substituted 2,6-dialkylmorpholines
09/12/2006US7105661 producing nucleic acid (DNA or RNA) fragments enzymatically extended with morpholino-nucleoside triphosphates; dna polymerases
09/12/2006US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
09/12/2006US7105507 Cyclohexane derivatives and their use as therapeutic agents
09/08/2006WO2006094236A1 N-phenyl benzamide derivatives as sirtuin modulators
09/08/2006WO2006077025A3 Morpholines as 5ht2c agonists
09/08/2006CA2599989A1 N-phenyl benzamide derivatives as sirtuin modulators
09/07/2006US20060199957 Novel bicyclic and tricyclic cannabinoids
09/07/2006US20060199826 Cyclopropane compounds and pharmaceutical use thereof
09/06/2006EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions
09/06/2006EP1697353A2 Aralkyl and aralkylidene heterocyclic lactams with affinity for 5-ht1 receptors
09/06/2006EP1517894B1 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin antagonists and/or serotonin reuptake inhibitors
09/06/2006CN1829695A Aminoquinoline derivatives and their use as adenosine A3 ligands
09/05/2006USRE39263 2-2-fluoro-5-ethylsulphonylamino-4-thiocarbamoyl-phenyl)-5,6,7,8-tetrahydro-1,2,4triazolo[4,3-a]pyridin-3(2H)-one; post or preemergent
09/05/2006US7101999 Red fluorescence dyes; labels
09/05/2006US7101882 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
09/05/2006US7101876 Substituted benzoxazines as integrin antagonists
08/2006
08/31/2006WO2006090235A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
08/31/2006WO2006089859A1 Novel drugs for treating respiratory diseases
08/31/2006US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma
08/31/2006DE102005008921A1 Neue Arzneimittel zur Behandlung von Atemwegserkrankungen New drugs for the treatment of respiratory disorders
08/31/2006CA2598914A1 Novel drugs for treating respiratory diseases
08/31/2006CA2598518A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
08/30/2006EP1694656A1 Benzoxazine derivatives and uses thereof
08/30/2006EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof
08/30/2006CN1824659A Synthesis method of butadiene morpholine
08/30/2006CN1272324C Novel herbicides
08/24/2006WO2006088720A2 9-substituted tetracyclines
08/24/2006WO2006087935A1 Pharmaceutical composition containing phenoxazinium compound as active ingredient
08/24/2006CA2597870A1 9-substituted tetracyclines
08/23/2006CN1821241A Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/23/2006CN1821217A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
08/22/2006US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction
08/17/2006WO2006086705A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
08/17/2006WO2006085978A2 Conjugates of a cephalosporin derivative and a fluorophor precursor and related compounds as substrates for beta-lactamase gene expression
08/17/2006WO2006084368A1 Fluorinated phno and analogs thereof
08/17/2006WO2006023158A3 Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds
08/17/2006WO2006021213A3 Vasopressin v1a antagonists
08/17/2006WO2006007532A3 2-substituted heteroaryl compounds
08/17/2006US20060183918 Beta 2-adrenergic receptor agonists
08/17/2006US20060183739 Carbonyl compounds
08/17/2006US20060183720 such as (4S,4aS,5aR,12aS)-9-[(N-cyclohexyl-N-hydroxyglycyl)amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, useful as antimicrobial agents and exhibit antibacterial activity against a wide spectrum of microorganisms
08/17/2006CA2598429A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
08/17/2006CA2597798A1 Fluorinated phno and analogs thereof
08/16/2006EP1689725A1 Resolution process for preparing (+)-(2s, 3s)-2-(3-chlorophenyl)-3,3,3-trimethyl-2-morpholinol
08/16/2006EP1689698A1 Bis-cationic compounds and use thereof
08/16/2006EP1689493A1 Calcitonin gene related peptide receptor antagonists
08/16/2006EP1019075B9 Beta 2-adrenergic receptor agonists
08/16/2006EP0980362B1 Substituted heterocycles and their use in medicaments
08/16/2006CN1817869A Process for the industrial synthesis of substitute thiophenecarboxydimethylester and application of the compound
08/10/2006WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/10/2006WO2006082495A1 Peroxisome proliferator activated receptor modulators
08/10/2006US20060178510 2-Benzyl-substituted: 2-(4-Methoxy-3-trifluoromethyl-benzyl)-morpholine, 2-(4-Methoxy-3-trifluoromethyl-benzyl)-morpholine, 2-[3-Chloro-4-(5-methyl-isoxazol-3-ylmethoxy)-benzyl]-morpholine; lipase inhibitor; central nervous system disorders, antidiabetic agents
08/10/2006US20060178372 Therapeutic quinoline compounds
08/10/2006CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/09/2006EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
08/09/2006EP1687638A2 Analysis of mass spectral data in the quiet zones
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 112